PWA
ADMA icon

Physician Wealth Advisors’s ADMA Biologics ADMA Stock Holding History

Physician Wealth Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32
Closed -$584 – 2061
2025
Q4 		$584 Buy
+32
New +$539 ﹤0.01% 1801
2025
Q3 		– Sell
-25
Closed -$456 – 1902
2025
Q2 		$456 Buy
+25
New +$510 ﹤0.01% 1737

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Physician Wealth Advisors's ADMA Position: Q1 2026 in Review

Physician Wealth Advisors sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 32 shares — an estimated $584 sold.

Physician Wealth Advisors first reported a position in ADMA in Q2 2025 and held it in 2 quarters. The position peaked at $584 in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Physician Wealth Advisors reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 32 ADMA Biologics shares in Q1 2026, an estimated $584.
  • Physician Wealth Advisors first reported a position in ADMA Biologics in Q2 2025 and held it in 2 quarters.
  • Physician Wealth Advisors's ADMA Biologics position peaked at $584 in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.